ATMIN Is Required for Maintenance of Genomic Stability and Suppression of B Cell Lymphoma

Cancer Cell

Volumn 19, Issue 5, 2011, Pages 587-600

  Loizou, Joanna I ^a   Sancho, Rocio ^a   Kanu, Nnennaya ^a   Bolland, Daniel J ^b   Yang, Fengtang ^c   Rada, Cristina ^d   Corcoran, Anne E ^b   Behrens, Axel ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; CANCER INHIBITION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; GENE LOCUS; GENOMIC INSTABILITY; MITOTIC RECOMBINATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM;

MUS;

EID: 79955970989     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.03.022     Document Type: Article

References (50)

1. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
2. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 1996, 86:159-171.
3. Bartkova J., Horejsi Z., Koed K., Kramer A., Tort F., Zieger K., Guldberg P., Sehested M., Nesland J.M., Lukas C., et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434:864-870.
4. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
5. Bunting S.F., Callen E., Wong N., Chen H.T., Polato F., Gunn A., Bothmer A., Feldhahn N., Fernandez-Capetillo O., Cao L., et al. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 2010, 141:243-254.
6. Callen E., Nussenzweig M.C., Nussenzweig A. Breaking down cell cycle checkpoints and DNA repair during antigen receptor gene assembly. Oncogene 2007, 26:7759-7764.
7. Callen E., Jankovic M., Difilippantonio S., Daniel J.A., Chen H.T., Celeste A., Pellegrini M., McBride K., Wangsa D., Bredemeyer A.L., et al. ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell 2007, 130:63-75.
8. Callen E., Jankovic M., Wong N., Zha S., Chen H.T., Difilippantonio S., Di Virgilio M., Heidkamp G., Alt F.W., Nussenzweig A., Nussenzweig M. Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes. Mol. Cell 2009, 34:285-297.
9. Camacho E., Hernandez L., Hernandez S., Tort F., Bellosillo B., Bea S., Bosch F., Montserrat E., Cardesa A., Fernandez P.L., Campo E. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 2002, 99:238-244.
10. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., et al. Genomic instability in mice lacking histone H2AX. Science 2002, 296:922-927.
11. D'Amours D., Jackson S.P. The Mre11 complex: at the crossroads of dna repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 2002, 3:317-327.
12. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000, 404:510-514.
13. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 2002, 196:469-480.
14. Difilippantonio S., Celeste A., Fernandez-Capetillo O., Chen H.T., Reina San Martin B., Van Laethem F., Yang Y.P., Petukhova G.V., Eckhaus M., Feigenbaum L., et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat. Cell Biol. 2005, 7:675-685.
15. Fang N.Y., Greiner T.C., Weisenburger D.D., Chan W.C., Vose J.M., Smith L.M., Armitage J.O., Mayer R.A., Pike B.L., Collins F.S., Hacia J.G. Oligonucleotide microarrays demonstrate the highest frequency of ATM mutations in the mantle cell subtype of lymphoma. Proc. Natl. Acad. Sci. USA 2003, 100:5372-5377.
16. Haidar M.A., Kantarjian H., Manshouri T., Chang C.Y., O'Brien S., Freireich E., Keating M., Albitar M. ATM gene deletion in patients with adult acute lymphoblastic leukemia. Cancer 2000, 88:1057-1062.
17. Hickson I., Zhao Y., Richardson C.J., Green S.J., Martin N.M., Orr A.I., Reaper P.M., Jackson S.P., Curtin N.J., Smith G.C. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004, 64:9152-9159.
18. Kanu N., Behrens A. ATMIN defines an NBS1-independent pathway of ATM signalling. EMBO J. 2007, 26:2933-2941.
19. Kanu N., Penicud K., Hristova M., Wong B., Irvine E., Plattner F., Raivich G., Behrens A. The ATM cofactor ATMIN protects against oxidative stress and prevents accumulation of DNA damage in the ageing brain. J. Biol. Chem. 2010, 285:38534-38542.
20. Kracker S., Bergmann Y., Demuth I., Frappart P.O., Hildebrand G., Christine R., Wang Z.Q., Sperling K., Digweed M., Radbruch A. Nibrin functions in Ig class-switch recombination. Proc. Natl. Acad. Sci. USA 2005, 102:1584-1589.
21. Lee J.H., Paull T.T. Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex. Science 2004, 304:93-96.
22. Liyanage M., Weaver Z., Barlow C., Coleman A., Pankratz D.G., Anderson S., Wynshaw-Boris A., Ried T. Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice. Blood 2000, 96:1940-1946.
23. Lumsden J.M., McCarty T., Petiniot L.K., Shen R., Barlow C., Wynn T.A., Morse H.C., Gearhart P.J., Wynshaw-Boris A., Max E.E., Hodes R.J. Immunoglobulin class switch recombination is impaired in Atm-deficient mice. J. Exp. Med. 2004, 200:1111-1121.
24. Maia S., Haining W.N., Ansen S., Xia Z., Armstrong S.A., Seth N.P., Ghia P., den Boer M.L., Pieters R., Sallan S.E., et al. Gene expression profiling identifies BAX-delta as a novel tumor antigen in acute lymphoblastic leukemia. Cancer Res. 2005, 65:10050-10058.
25. Mallette F.A., Gaumont-Leclerc M.F., Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev. 2007, 21:43-48.
26. Matei I.R., Gladdy R.A., Nutter L.M., Canty A., Guidos C.J., Danska J.S. ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes. Blood 2007, 109:1887-1896.
27. McKinnon P.J. ATM and ataxia telangiectasia. EMBO Rep. 2004, 5:772-776.
28. McNees C.J., Conlan L.A., Tenis N., Heierhorst J. ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage. EMBO J. 2005, 24:2447-2457.
29. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
30. Neuberger M.S., Harris R.S., Di Noia J., Petersen-Mahrt S.K. Immunity through DNA deamination. Trends Biochem. Sci. 2003, 28:305-312.
31. Nussenzweig A., Nussenzweig M.C. Origin of chromosomal translocations in lymphoid cancer. Cell 2010, 141:27-38.
32. Oka H., Sakai W., Sonoda E., Nakamura J., Asagoshi K., Wilson S.H., Kobayashi M., Yamamoto K., Heierhorst J., Takeda S., Taniguchi Y. DNA damage response protein ASCIZ links base excision repair with immunoglobulin gene conversion. Biochem. Biophys. Res. Commun. 2008, 371:225-229.
33. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103.
34. Reina-San-Martin B., Chen H.T., Nussenzweig A., Nussenzweig M.C. ATM is required for efficient recombination between immunoglobulin switch regions. J. Exp. Med. 2004, 200:1103-1110.
35. Reina-San-Martin B., Nussenzweig M.C., Nussenzweig A., Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc. Natl. Acad. Sci. USA 2005, 102:1590-1595.
36. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., Catalan N., Forveille M., Dufourcq-Labelouse R., Gennery A., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
37. Robbiani D.F., Bunting S., Feldhahn N., Bothmer A., Camps J., Deroubaix S., McBride K.M., Klein I.A., Stone G., Eisenreich T.R., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 2009, 36:631-641.
38. Saidi A., Li T., Weih F., Concannon P., Wang Z.Q. Dual functions of Nbs1 in the repair of DNA breaks and proliferation ensure proper V(D)J recombination and T-cell development. Mol. Cell. Biol. 2010, 30:5572-5581.
39. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 1995, 268:1749-1753.
40. Schaffner C., Stilgenbauer S., Rappold G.A., Dohner H., Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999, 94:748-753.
41. Schaffner C., Idler I., Stilgenbauer S., Dohner H., Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc. Natl. Acad. Sci. USA 2000, 97:2773-2778.
42. Spring K., Cross S., Li C., Watters D., Ben-Senior L., Waring P., Ahangari F., Lu S.L., Chen P., Misko I., et al. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res. 2001, 61:4561-4568.
43. Spring K., Ahangari F., Scott S.P., Waring P., Purdie D.M., Chen P.C., Hourigan K., Ramsay J., McKinnon P.J., Swift M., Lavin M.F. Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat. Genet. 2002, 32:185-190.
44. Stankovic T., Stewart G.S., Fegan C., Biggs P., Last J., Byrd P.J., Keenan R.D., Moss P.A., Taylor A.M. Ataxia telangiectasia mutated-deficient B-cell chronic lymphocytic leukemia occurs in pregerminal center cells and results in defective damage response and unrepaired chromosome damage. Blood 2002, 99:300-309.
45. Stilgenbauer S., Winkler D., Ott G., Schaffner C., Leupolt E., Bentz M., Moller P., Muller-Hermelink H.K., James M.R., Lichter P., Dohner H. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood 1999, 94:3262-3264.
46. Stracker T.H., Theunissen J.W., Morales M., Petrini J.H. The Mre11 complex and the metabolism of chromosome breaks: the importance of communicating and holding things together. DNA Repair (Amst.) 2004, 3:845-854.
47. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 2003, 22:5612-5621.
48. Wang J.H., Gostissa M., Yan C.T., Goff P., Hickernell T., Hansen E., Difilippantonio S., Wesemann D.R., Zarrin A.A., Rajewsky K., et al. Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 2009, 460:231-236.
49. Xu Y., Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 1996, 10:2401-2410.
50. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyn M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 1996, 10:2411-2422.